INSIGHTS ON SOLID DOSE MANUFACTURING
-
![GettyImages-2176475661 tabet press, pharma manufacturing]( "Navigating High-Potency OSD Manufacturing")
Navigating High-Potency OSD ManufacturingLearn how containment strategy, process design, and early risk‑based decisions influence operator protection, compliance, and long‑term manufacturing success as potency levels continue to rise.
-
![tablets-GettyImages-1434708636]( "Lower Punch Tip Bending / Buckling")
Lower Punch Tip Bending / BucklingWhen manufacturing mini-tablets, adjusting punch force ratings is crucial to prevent bending or buckling. The Rankine-Gordon formula offers a safer force rating for microtip tooling.
-
![cdmo-solid-dose-GettyImages-1432665138]( "How To Achieve Late-Phase Success In Complex OSD Development")
How To Achieve Late-Phase Success In Complex OSD DevelopmentLate-phase OSD scale-up demands more than technical know-how. This paper examines the frameworks, tools, and partnership models that determine whether promising molecules reach commercial production reliably.
-
![GettyImages-1352293764-doctor-child-teddy-bear-office]( "Paediatric Drug Product Development Through To Commercialisation")
Paediatric Drug Product Development Through To CommercialisationLearn how an innovative pediatric minitablet achieved patient-friendly administration, precise dosing and scalable manufacturing to support a smooth path to market.
-
Advancements In GLP-1 Analog Formulation: Overcoming Challenges2/3/2025
Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.
-
Small-Scale Automatic Micro-Dosing Of Powders Into Blisters9/2/2026
Optimize inline X-ray fill weight verification with precise blister calibration, automated HMI calibration file creation, and 2D code tracking.
-
Enabling Complex Phase IIa Dosing Through Flexible Clinical Packaging Design5/6/2026
Discover how flexible, patient‑centric clinical packaging supports complex Phase IIa dosing while protecting timelines, ensuring compliance, and avoiding costly primary packaging changes.
-
Oral Delivery Of PROTACs: Integrating Molecular Design And Enabling Formulation8/20/2026
Explore how integrated molecular design and formulation strategies can overcome the unique oral-delivery challenges of PROTACs, transforming complex degraders into viable, scalable medicines.
-
Converting From A Spray-Dried Dispersion To A KinetiSol Formulation In <5 Months2/26/2026
A development team quickly turned a low‑bioavailability, high‑burden formulation into a streamlined, clinically improved version, boosting exposure, simplifying manufacturing, and accelerating progress.
SOLID DOSE MANUFACTURING SOLUTIONS
-
![Pharmacontainment]( "Pharmaceutical Containment Systems, RABS, Isolators")
Inno4Life, part of the Dec Group, has in-depth knowledge and containment equipment solutions for the aseptic/sterile Fill-Finish pharmaceutical industry. In line with ISO 14644, including monitoring of viable and non-viable monitoring to comply with the most recent revisions of the ISPE containment specifications cGMP and GAMP5 guidelines.
-
![Open-Restricted-Access-Barrier-System]( "Open Restricted Access Barrier System (RABS) From Franz Ziel")
Open RABS as a housing for aseptic processes, e.g., filling, loading, and unloading of freeze dryers. Product protection is achieved by a barrier (oRABS housing with gloves) between the operator and the product.
-
![GettyImages-993779840-stick-pack-manufacturing-packaging]( "A Future-Ready Solution For Pharmaceutical And Nutraceutical Packaging")
High-output stickpack production meets flexibility and sustainability with an integrated line designed for precise dosing and scalable performance—supporting efficient single-dose packaging.
-
![GENiSYS C rendering]( "Biosimilar Development Aseptic Filling Equipment")
With many of the blockbuster biologic drugs of the ’90s are coming off of patent, companies are racing to provide a clinically similar alternative to these pioneering products. Like any biologic drug, they require care and attentiveness throughout the manufacturing process. Therefore, it is necessary to maintain aseptic conditions throughout the production process of these drug products.
-
![science laboratory research, healthcare innovation, development, investigation-GettyImages-1751659695]( "Solutions For Your Oral Dose Challenges")
Oral dose development, manufacturing, packaging, and serialization under one quality system, supporting potent and controlled compounds from clinical supply through commercial launch.
